Cargando…
Overexpression of PTK6 predicts poor prognosis in bladder cancer patients
Protein tyrosine kinase 6 (PTK6) is a non-receptor tyrosine kinase and works as an oncogene in various cancers. Recently, PTK6 has been used as a therapeutic target for breast cancer patients in a clinical study. However, the prognostic value of PTK6 in bladder cancer (BC) remains vague. Therefore,...
Autores principales: | Xu, Xue-lian, Ye, Yun-Lin, Wu, Zhi-Ming, He, Qiu-Ming, Tan, Lei, Xiao, Kang-Hua, Wu, Rui-yan, Yu, Yan, Mai, Jia, Li, Zhi-ling, Peng, Xiao-dan, Huang, Yun, Li, Xuan, Zhang, Hai-liang, Zhu, Xiao-feng, Qin, Zi-Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687160/ https://www.ncbi.nlm.nih.gov/pubmed/29151930 http://dx.doi.org/10.7150/jca.21318 |
Ejemplares similares
-
Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma
por: Liu, Xue-Kui, et al.
Publicado: (2013) -
The overexpression of ZWINT in integrated bioinformatics analysis forecasts poor prognosis in breast cancer
por: Shao, Ming-Tao, et al.
Publicado: (2020) -
PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance
por: Tian, Xiuyun, et al.
Publicado: (2016) -
TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration
por: Xue, Jiapeng, et al.
Publicado: (2023) -
Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)